SCHEMBL6988367

SCHEMBL6988367

Cc1n[c][nH]c1-c1cncnc1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.31
DYRK1A Q13627 1/20 0.30
DYRK1B Q9Y463 1/20 0.30
PIM1 P11309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL557663 0.73 KDM4E (0.41)
SCHEMBL7360850 0.72 PIM1 (0.33) ATMPIM1
SCHEMBL2814958 0.60 ATM (0.65) ATM
SCHEMBL6986571 0.60 PIM1 (0.33) ATMPIM1
SCHEMBL26951480 0.57 CYP17A1 (0.40) ATMPIM1
SCHEMBL3431562 0.57
SCHEMBL12951374 0.57 ATM (0.46) ATMPIM1
SCHEMBL10547 0.56
SCHEMBL13910998 0.56 ATM (0.50) ATM
SCHEMBL2553484 0.55 ATM (0.56) ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337251-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2003-08-27 EP disclosed
WO-2002102380-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-12-27 WO disclosed